257
Participants
Start Date
October 31, 2003
Primary Completion Date
January 31, 2014
Study Completion Date
September 30, 2016
cyclophosphamide
Part of planned chemotherapy regimen
goserelin acetate
Given subcutaneously
Auckland City Hospital, Auckland
Centre Hospitalier Universitaire Vaudois, Lausanne
National Institute of Oncology, Budapest
Mater Hospital - North Sydney, North Sydney
Royal North Shore Hospital, St Leonards
Newcastle Mater Misericordiae Hospital, Waratah
Peter MacCallum Cancer Centre, East Melbourne
Royal Melbourne Hospital, Parkville
St. Vincent's Hospital - Melbourne, Fitzroy
Box Hill Hospital, Box Hill
Maroondah Hospital, East Ringwood
Monash Medical Center - Clayton Campus, Clayton
Ballarat Oncology and Haematology Services, Ballarat
Regionalspital, Thun
Centre Hospitalier Regional de la Citadelle, Liège
Centre Hospitalier Hutois, Huy
Royal Adelaide Hospital Cancer Centre, Adelaide
Flinders Medical Centre, Bedford Park
Royal Perth Hospital, Perth
Royal Hobart Hospital, Hobart
AZ Damiaan, Ostend
Ospedale degli Infermi - ASL 12, Biella
European Institute of Oncology, Milan
Ospedale Alessandro Manzoni, Lecco
Ospedali Riuniti di Bergamo, Bergamo
Ospedale Civile Ramazzini, Carpi
U.Z. Gasthuisberg, Leuven
CHU Liege - Domaine Universitaire du Sart Tilman, Liège
Centre Hospitalier Peltzer-La Tourelle, Verviers
Oncology Institute of Southern Switzerland, Bellinzona
Inselspital Bern, Bern
Oncology Institute of Southern Switzerland - Locarno, Locarno
Oncology Institute of Southern Switzerland - Lugano, Lugano
Oncology Institute of Southern Switzerland - Mendrisio, Mendrisio
National Cancer Institute (NCI)
NIH
Cancer and Leukemia Group B
NETWORK
Eastern Cooperative Oncology Group
NETWORK
ETOP IBCSG Partners Foundation
NETWORK
SWOG Cancer Research Network
NETWORK